Trials / Completed
CompletedNCT03566914
Tadalafil for Erectile Dysfunction in Patients With Cirrhosis
A Randomized Placebo Controlled Trial of Tadalafil for Erectile Dysfunction in Patients With Cirrhosis
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 140 (actual)
- Sponsor
- Institute of Liver and Biliary Sciences, India · Academic / Other
- Sex
- All
- Age
- 21 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
This study will be conducted into two parts 1) Screening of 400 cases of cirrhosis (Child A,child B and child c) for the prevalence and risk factors of erectile dysfunction in cirrhosis.2) The part 2 is RCT as follows where 70 cases in each arm will be taken wuth child A and child B cirrhosis for the effect of treatment on erectile dysfunction (Tadalafil vs Placebo). After getting informed consent. Clinical, anthropometric and biochemical assessment will be done by candidate, co-supervisors and supervisor. Screening and selection criteria by using various questionnaire like Karnofsky Performance Score (KPS) , IIEF Questionnaire , ADAMS Questionnaire, Generalized Anxiety Disorder 7 (GAD-7) questionnaire, Patient Health Questionnaire (PHQ-9 for depression ; and SF-36 questionnaire). The informed consent will be obtained from the participants in the study. Patients-ED IIEF\<25 will be included as per inclusion and exclusion criteria. Tadalfil regimen: 10 mg daily at any time before anticipated sexual activity on days with anticipated sexual activity On days with no anticipated sexual activity: 10 mg daily at night after meals. Follow-up1 week, 2weeks, 4weeks, 12 weeks with history, clinical examination and laboratory test.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tadalafil 10 MG | Tadalafil 10 mg per oral once daily for 3 months |
| OTHER | Placebo | TPlacebo tablet per oral once daily for 3 months |
Timeline
- Start date
- 2018-06-30
- Primary completion
- 2019-12-28
- Completion
- 2019-12-28
- First posted
- 2018-06-25
- Last updated
- 2021-07-06
Locations
1 site across 1 country: India
Source: ClinicalTrials.gov record NCT03566914. Inclusion in this directory is not an endorsement.